The revised Alzheimer’s disease diagnostic criteria highlight that amyloidosis is essentially a prerequisite of Alzheimer’s disease tauopathy,3 underscoring the need to study how brain volumes associate with tau in the presence of amyloid. This evidence concerns the gene MAPT and Alzheimer disease.